(Q34247793)

31 July 2017

title

Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients (English)

1 reference

31 July 2017

1 reference

1 reference

9

Ching-Hon Pui

1 reference

31 July 2017

11

Mary V Relling

1 reference

31 July 2017

6

Clinton F Stewart

1 reference

31 July 2017

author name string

Anthony M Christensen

1

1 reference

31 July 2017

Jennifer L Pauley

2

1 reference

31 July 2017

Alejandro R Molinelli

3

1 reference

31 July 2017

John C Panetta

4

1 reference

31 July 2017

Deborah A Ward

5

1 reference

31 July 2017

James M Hoffman

7

1 reference

31 July 2017

Scott C Howard

8

1 reference

31 July 2017

Alberto S Pappo

10

1 reference

31 July 2017

Kristine R Crews

12

1 reference

31 July 2017

language of work or name

English

0 references

publication date

17 January 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

118

1 reference

31 July 2017

issue

17

1 reference

31 July 2017

page(s)

4321-4330

1 reference

Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Glucarpidase following high-dose methotrexate: update on development

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Treating childhood acute lymphoblastic leukemia without cranial irradiation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Understanding and managing methotrexate nephrotoxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Carboxypeptidase G2 rescue in delayed methotrexate elimination in renal failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

High-dose leucovorin as sole therapy for methotrexate toxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Concepts in use of high-dose methotrexate therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713608

Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy

6 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

Optimal management of methotrexate intoxication in a child with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27378

Successful carboxypeptidase G2 rescue in delayed MTX-elimination due to renal failure

21 January 2018

1 reference

12 December 2020

Patient characteristics associated with high-risk methotrexate concentrations and toxicity

1 reference

12 December 2020

Successful carboxypeptidase G2 rescue of a high-risk elderly Hodgkin lymphoma patient with methotrexate intoxication and renal failure

1 reference

12 December 2020

Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2

1 reference

12 December 2020

Liquid-liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma

1 reference

12 December 2020

Carboxypeptidase G2 rescue after high-dose methotrexate

1 reference

12 December 2020

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect

1 reference

12 December 2020

Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use

1 reference

12 December 2020

Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation

1 reference

12 December 2020

The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.27378

1 reference

31 July 2017

1 reference

31 July 2017

1 reference